tiprankstipranks
Advertisement
Advertisement

PHR Stock Latest News

Phreesia price target lowered to $12 from $15 at KeyBanc
The FlyPhreesia price target lowered to $12 from $15 at KeyBanc
8d ago
PHR
William Blair healthcare IT analysts hold analyst/industry conference call
PremiumThe Fly
William Blair healthcare IT analysts hold analyst/industry conference call
10d ago
DH
MD
Phreesia price target lowered to $15 from $25 at Wells Fargo
PremiumThe Fly
Phreesia price target lowered to $15 from $25 at Wells Fargo
15d ago
PHR
Buy Rating on Valuation and Earnings Power as Market Overreacts to Concentrated Slowdown Risks
PremiumRatings
Buy Rating on Valuation and Earnings Power as Market Overreacts to Concentrated Slowdown Risks
15d ago
PHR
Phreesia Earnings Call: Profit Breakthrough, Growth Reset
PremiumCompany Announcements
Phreesia Earnings Call: Profit Breakthrough, Growth Reset
16d ago
PHR
Integration Risks Cloud Phreesia’s AccessOne Deal, Threatening Synergies and Share Performance
PremiumCompany AnnouncementsIntegration Risks Cloud Phreesia’s AccessOne Deal, Threatening Synergies and Share Performance
19d ago
PHR
Phreesia downgraded to Market Perform from Outperform at Citizens
Premium
The Fly
Phreesia downgraded to Market Perform from Outperform at Citizens
20d ago
PHR
Video: Deals in food and pharmaceuticals headline busy morning of M&A
Premium
The Fly
Video: Deals in food and pharmaceuticals headline busy morning of M&A
20d ago
UL
LLY
Phreesia price target lowered to $20 from $32 at Stephens
PremiumThe Fly
Phreesia price target lowered to $20 from $32 at Stephens
21d ago
PHR
Phreesia price target lowered to $14 from $32 at BMO Capital
PremiumThe Fly
Phreesia price target lowered to $14 from $32 at BMO Capital
21d ago
PHR
Phreesia price target lowered to $14 from $35 at Needham
PremiumThe Fly
Phreesia price target lowered to $14 from $35 at Needham
21d ago
PHR
Phreesia price target lowered to $22 from $32 at Canaccord
PremiumThe Fly
Phreesia price target lowered to $22 from $32 at Canaccord
21d ago
PHR
Phreesia downgraded to Neutral from Buy at Citi
PremiumThe FlyPhreesia downgraded to Neutral from Buy at Citi
21d ago
PHR
Phreesia downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Phreesia downgraded to Neutral from Overweight at JPMorgan
21d ago
PHR
Phreesia downgraded to Neutral from Outperform at Baird
Premium
The Fly
Phreesia downgraded to Neutral from Outperform at Baird
21d ago
PHR
Phreesia downgraded to Hold from Buy at Truist
PremiumThe Fly
Phreesia downgraded to Hold from Buy at Truist
21d ago
PHR
Phreesia: Solid Operating Leverage but Regulatory Headwinds and Slowing Life Sciences Growth Warrant Hold Rating
PremiumRatings
Phreesia: Solid Operating Leverage but Regulatory Headwinds and Slowing Life Sciences Growth Warrant Hold Rating
21d ago
PHR
Balanced View on Phreesia: Solid Profitability Gains Offset by Weaker Growth Visibility and Elevated Execution Risk Supporting a Hold Rating
PremiumRatings
Balanced View on Phreesia: Solid Profitability Gains Offset by Weaker Growth Visibility and Elevated Execution Risk Supporting a Hold Rating
21d ago
PHR
Balanced View on Phreesia: Solid Profitability and Valuation Support Offset by Growth Uncertainty and Estimate Revisions
PremiumRatings
Balanced View on Phreesia: Solid Profitability and Valuation Support Offset by Growth Uncertainty and Estimate Revisions
21d ago
PHR
Closing Bell Movers: Phreesia down over 20% after guidance cut
PremiumThe FlyClosing Bell Movers: Phreesia down over 20% after guidance cut
21d ago
CVV
PHR
Phreesia cuts FY27 revenue view to $510M-$520M from $545M-$559M
Premium
The Fly
Phreesia cuts FY27 revenue view to $510M-$520M from $545M-$559M
21d ago
PHR
Phreesia down 21% at $9.00 after Q4 earnings, guidance cut
Premium
The Fly
Phreesia down 21% at $9.00 after Q4 earnings, guidance cut
21d ago
PHR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >